Navigation Links
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Date:11/28/2008

that the product will receive regulatory approval for chronic pain, or that it will continue to be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filings with the United States Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

    (i)    Chappell, A. et al. Duloxetine 60 to 120 mg versus Placebo in the
           Treatment of Patients with Osteoarthritis Knee Pain. Poster
           presented at the European League Against Rheumatism. 13 June 2008.
    (ii)   Skljarevski, V. et al. Efficacy of Duloxetine in Chronic Low Back
           Pain.  Poster presented at the European Federation of Neurological
           Societies Annual Congress. 25 August 2008.
    (iii)  Skljarevski, V. et al. Duloxetine versus Placebo in the Treatment
           of Chronic Low Back Pain.  Poster presented at the 12th World
           Congress of Pain. 21 August 2008.
    (iv)   APF 2008.
    (v)    NIH 1998.
    (vi)   Fox et al. 2000.
    (vii)  Stewart et al. 2003.
    (viii) White et al. 2005.

    (Logo:http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application
2. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
3. Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimers Disease Compound
4. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
5. Phase II Data on Lillys Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimers Disease
6. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
7. Lilly and TransPharma Medical Announce Licensing and Development Agreement
8. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
9. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
10. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
11. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 2015  EnteroMedics Inc. (NASDAQ: ETRM ), a ... to treat obesity, metabolic diseases, and other gastrointestinal disorders, ... of its previously announced underwritten public offering of 40,229,886 ... per unit. Canaccord Genuity was acting ... acting as co-manager for the offering. The ...
(Date:7/6/2015)... -- Impax Laboratories, Inc. (NASDAQ: IPXL ) announced today ... financial results on Monday, August 10, 2015, prior to ... will host a conference call and live webcast with ... August 10, 2015. The financial results and ... section of the Company,s Web site at http://investors.impaxlabs.com ...
(Date:7/6/2015)... 6, 2015  Nitin Tandon, M.D., UTHealth neurosurgeon ... Memorial Hermann Mischer Neuroscience Institute at the ... System technology into the skull of a 36-year-old ... seizures – the first time this procedure has ... "Epilepsy is a neurological condition that affects nearly ...
Breaking Medicine Technology:EnteroMedics Inc. Announces Termination of Public Offering of Common Stock and Warrants 2Impax to Report Second Quarter 2015 Results on August 10, 2015 2Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 2Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 3Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 4
... March 16 ExonHit Therapeutics,(Alternext: ALEHT) today reported ... by Institut Gustave Roussy, which describes the,identification of ... the,analysis of alternative RNA splicing [1]. Study data ... benign lesions, and alternative,transcripts determine the molecular characteristics ...
... WORTH, Texas, March 13 At the Health Industries ... Ph.D. and professor of public health and behavioral sciences ... Center,s School of Public Health, announced new findings ... economy. Specifically, unemployment and reduced spending on health ...
Cached Medicine Technology:ExonHit Reports Proof-of-Concept in Breast Cancer Diagnostic Using its SpliceArray(TM) Platform 2ExonHit Reports Proof-of-Concept in Breast Cancer Diagnostic Using its SpliceArray(TM) Platform 3ExonHit Reports Proof-of-Concept in Breast Cancer Diagnostic Using its SpliceArray(TM) Platform 4Unemployment, Health Care Spending Affect Mortality 2
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... For ... finding medical providers for personal injury victims. Throughout the company’s history the goal ... deliver the care victims need in their recovery. And while Doctors on Liens ...
(Date:7/6/2015)... ... July 06, 2015 , ... Respected southern California personal injury attorney Fernando ... him as an attorney who has sharp legal skills as well as a superior ... for 2015 from Martindale-Hubbell and a Top 10 Award from The National Academy of ...
(Date:7/6/2015)... ... , ... University of Pittsburgh Cancer Institute (UPCI) scientists recently led ... newly available tests that better incorporate personalized medicine into diagnosing the condition. , ... is published in the July issue of the scientific journal Thyroid . ...
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... Shortly ... on Liens , the leading network of doctors working on a lien basis. ... Doctors on Liens. , The daughter of two Cambodian refugees, Dr. Lim suffered with ...
(Date:7/6/2015)... Beach, Virginia (PRWEB) , ... July 06, 2015 ... ... States choose fat-reduction procedures each year for aesthetic reasons, which is why liposuction ... country. For a particular demographic, however, fat reduction has become more than a ...
Breaking Medicine News(10 mins):Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 5Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3
... FAIRFAX, Va., Oct. 24 Kathleen M. Foley, ... City, and Perry Fine,MD, of the University of ... in Education and Leadership Award for 2007 at ... The award recognizes,contributors to the advancement of palliative ...
... improved efficacy and reduced toxicity, studies find, , , WEDNESDAY, ... chemotherapy drug, docetaxel, to the standard two-drug regimen used ... the treatment while reducing the toxicity, two new studies ... effective that it increased survival in both studies and ...
... Norway October 24, 2007 - The use of ... increased incidence of reproductive endocrine disorders in both men ... the effects of withdrawal from two common AEDs, carbamazepine ... and female AED users. , The study finds ...
... New research results from the University at Buffalos Research ... aware of and accurately evaluate the extent of their ... use., Researchers also found that in cases where parents ... twice as likely to underestimate frequency of marijuana use ...
... by needles, experts say , , WEDNESDAY, Oct. 24 (HealthDay ... can be given the nasal spray influenza vaccine FluMist, ... only recommended for healthy people ages 5 to 49. ... than 5, but the advisers said Wednesday that FluMist ...
... to Leverage Zagat,s, Expertise to Survey Physicians; WellPoint Members ... Rate Experiences Using Zagat,s Renowned 30-Point ... WellPoint, Inc., the,nation,s largest health benefits company, and Zagat ... online survey tool that will allow,consumers to share their ...
Cached Medicine News:Health News:Two Physicians Recognized for Work in Pain and Symptom Management 2Health News:Three Chemo Drugs Better Than Two for Advanced Head/Neck Cancers 2Health News:Three Chemo Drugs Better Than Two for Advanced Head/Neck Cancers 3Health News:Gauging parent knowledge about teens' substance use 2Health News:Gauging parent knowledge about teens' substance use 3Health News:U.S. Advisers OK Nasal Spray Flu Vaccine for Young Children 2Health News:U.S. Advisers OK Nasal Spray Flu Vaccine for Young Children 3Health News:WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors 2Health News:WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: